Outsourcing in Clinical Trials Southern California 2021
In light of the recent global developments around the COVID-19 virus, we have made the unavoidable decision to postpone Outsourcing in Clinical Trials Southern California. The event will now take place on 29th & 30th September 2021.
Arena International are delighted to announce the return of Outsourcing in Clinical Trials Southern California this October for its 8th Annual event!
Our 2021 programme boasts two full streams;
- Clinical Operations & Outsourcing
- Clinical Trial Technology & Innovation
Attendees will hear from AbbVie, Pfizer, Arena Pharmaceuticals, Bristol Myers Squibb, ClearFlow, Daré Bioscience and many more. Mary Syto, Director of Early Clinical Development at Bristol Myers Squibb, will be leading the Clinical Operations stream, whilst James Wabby, Executive Director of Regulatory Affairs & Combination Products/Device at AbbVie, will be heading up the Innovation stream.
Whether you are interested in debating the long term impacts COVID-19 will have on the future of clinical trials, or you want to get stuck into a discussion on best practices for strong CRO communications and building trust, there is something for everyone.
With a more interactive and hands on agenda including debates, workshops, roundtables, fireside chats and more, this event will create an environment where clinical trial teams from across all sizes of sponsor and vendor can work together to manage demands while ensuring patients are safeguarded at all stages.
Don’t miss out; join us in La Jolla on September 29th & 30th 2021!
ATTENDEES AT DIRECTOR + LEVEL
AG Mednet is a specialized, electronic image data capture and submission service dedicated to supporting clinical trials research. Sites use a protocol-specific, integrated workflow to assemble the highest quality, privacy-regulation-compliant imaging submissions possible. AG Mednet integrates with any EDC, guarantees delivery of images, and enables “hands-free” receipt of imaging submissions.
WCCT Global is a multi-site, full service CRO of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. WCCT has extensive experience with healthy volunteer studies including First-in-Human, as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.